Samuel Valable
10
Documents
Identifiants chercheurs
- samuel-valable
- ResearcherId : B-7578-2008
- 0000-0003-0355-0270
- IdRef : 085766127
- ResearcherId : http://www.researcherid.com/rid/B-7578-2008
Présentation
samuel valable,hypoxia
Publications
- 1
- 1
- 1
- 1
- 1
- 10
- 4
- 4
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 5
- 1
- 1
[ 18 F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [ 18 F]FDG in human xenograft modelsTheranostics, 2018, 8 (16), pp.4563-4573. ⟨10.7150/thno.26754⟩
Article dans une revue
hal-02006576v1
|
|
Chronic arterial hypertension impedes glioma growth: a multiparametric MRI study in the rat.Hypertension Research, 2015, 38 ((11)), pp.723-32. ⟨10.1038/hr.2015.66⟩
Article dans une revue
hal-01587404v1
|
[18F]Fludarabine-PET as a promising tool in differentiation between CNS lymphoma and glioblastoma: comparative analyses with [18F]FDG and [11C]MET in human xenograft modelsESMI, Mar 2018, San Sebastian, Spain
Poster de conférence
hal-02379585v1
|
|
[18F]Fludarabine-PET as a promising tool in differentiation between CNS lymphoma and glioblastoma: comparative analysis with [18F]FDG in human xenograft modelsJNRB CHU, Nov 2017, Caen, France
Poster de conférence
hal-02380577v1
|
|
CNS lymphoma imaging with [18F]fludarabine-PET: comparison with [18F]FDG in a human lymphoma xenograft modelWMIC, Sep 2017, Philadelphia, United States
Poster de conférence
hal-02386345v1
|